Back Other Health News

Other Infections

PAS 2017: New Approaches Help Babies with Opioid Withdrawal Syndrome

Letting mothers and babies room together and using methadone or buprenorphine instead of morphine to manage withdrawal symptoms leads to shorter stays and other benefits for newborns with neonatal abstinence syndrome (NAS), according to several presentations at the Pediatric Academic Societies Meeting this month in San Francisco.

alt

Read more:

HR17: Overamping Is a Common Problem Among People Who Use Stimulants

Overdosing on stimulants such as methamphetamine -- known as "overamping" -- is an under-recognized problem in a harm reduction community that more often focuses on opioid overdose, according to a presentation at the 25th Harm Reduction International Conference this week in Montreal.

alt

Read more:

PAS 2017: Vaccine Reduces Human Papillomavirus Prevalence Among Young Women

The prevalence of human papillomavirus (HPV) types included in the most widely used vaccine has decreased among adolescent and young women in the U.S., with "herd immunity" extending to those who were not vaccinated themselves, according to study results presented at the Pediatric Academic Societies Meeting last week in San Francisco.

alt

Read more:

HR17: Drug Checking Reveals High Levels of Fentanyl Contamination

A pilot project to check the purity of drugs at Vancouver's Insite safe injection facility found that around 80% of tested samples contained fentanyl, and people who learned their drugs were contaminated were more likely to reduce their doses and less likely to overdose, researchers reported at the 25th Harm Reduction International Conference this week in Montreal.

alt

Read more:

EASL 2017: Norfloxacin Reduces Risk of Death for People with Decompensated Cirrhosis

Long-term prophylaxis with the antibiotic norfloxacin significantly reduced the incidence of death in people with decompensated cirrhosis over a 6-month follow-up period, according to a French randomized trial reported at the EASL International Liver Congress this week in Amsterdam.

alt

Read more:

HR17: Hydromorphone Works as Well as Heroin-Assisted Drug Addiction Treatment

Hydromorphone was as effective as pharmaceutical heroin for opioid addiction treatment, but it was associated with fewer serious side effects, according to results from the SALOME trial presented at the 25th Harm Reduction International Conference this week in Montreal.

alt

Read more:

CROI 2017: Prednisone Reduces Risk of Developing TB-IRIS after Starting Antiretroviral Treatment

Prednisone reduces the risk of immune restoration inflammatory syndrome (IRIS) in people with HIV after starting tuberculosis (TB) treatment, a randomized trial called PredART has found. The results were presented last month at the Conference on Retroviruses and Opportunistic Infections in Seattle by Graeme Meintjes from the University of Cape Town in South Africa.

alt

Read more:

HR17: AA Amyloidosis Is an Unrecognized Problem Among People Who Inject Drugs

AA amyloidosis, a condition resulting from skin and soft tissue infections that can lead to kidney failure, may be more common than previously recognized among people who inject drugs, according to a presentation at the 25th Harm Reduction International Conference this week in Montreal.

alt

Read more:

CROI 2017: Isoniazid Preventive Therapy for TB Reduces Risk of Death for People Living with HIV

A 6-month course of isoniazid preventive treatment (IPT) for at the beginning of the Temprano trial in Ivory Coast reduced the risk of death by 37% over a mean follow-up period of 4.5 years, Anani Badje reported at the Conference on Retroviruses and Opportunistic Infections this month in Seattle.

alt

Read more: